Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting
Authors' conclusion
Initiation of Control-IQ technology in a real-world setting significantly reduced the impact of diabetes on daily life while simultaneously improving glycemic control.
Study context
- Population
- Youth aged 6–18 years with T1D using a Tandem t:slim X2 pump, and their parents; median (IQR) age 13.8 (11.1, 15.7) years, T1D duration 6.3 (3.1, 8.4) years
- Participants
- 59 participants
- Exposure
- End of study vs baseline after initiating Control-IQ
- Control-IQn = 59
- Outcome
- Quality of life (validated patient-reported outcome measures (PROMs)) and glycemic control
- Follow-up
- 16 weeks
Methodological detailssingle-centre, real-world
- Single-centre
- Real-world
Main finding
As reported in the abstract
Change in PROM scores, baseline to end of study
- INSPIRE scores lower for parents
- p = 0.04
- Diabetes Impact and Device Satisfaction (DIDS) Diabetes Impact, youth: mean difference
- −1.08 (−1.51, −0.64) (p < 0.001) (95% CI)
- DIDS Diabetes Impact, parents: mean difference
- −1.41 (−1.96, −0.87) (p < 0.001) (95% CI)
- DIDS Device Satisfaction, youth: mean difference
- +0.43 (0.11, 0.74) (p = 0.01) (95% CI)
- DIDS Device Satisfaction, parents: mean difference
- +0.58 (0.31, 0.85) (p < 0.001) (95% CI)
- Hypoglycemia Fear Survey, youth: mean difference
- −4.41 (−7.65, −1.17) (p = 0.01) (95% CI)
- Hypoglycemia Fear Survey, parents: mean difference
- −7.64 (−11.66, −3.62) (p < 0.001) (95% CI)
- WHO-5 Well-Being Index, youth: mean difference
- +5.10 (−1.40, 11.6) (p = 0.12) (95% CI)
- WHO-5 Well-Being Index, parents: mean difference
- +9.60 (3.40, 15.8) (p = 0.003) (95% CI)
Observational data: associations, not effects.
Further findings
- Mean TIR at baseline
- 52.6%
- Mean TIR at 4 weeks
- 62.6% (p < 0.001)
- Increase sustained to 16 weeks
Original publication
Control-IQ Technology Positively Impacts Patient Reported Outcome Measures and Glycemic Control in Youth with Type 1 Diabetes in a Real-World Setting. Pediatr Diabetes. Published 12 April 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →